{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:47:03Z","timestamp":1783529223811,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s12013-024-01342-5","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T17:01:27Z","timestamp":1718298087000},"page":"2321-2331","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["N6-methyladenosine (m6A) Writer WTAP Potentiates Hepatocellular Carcinoma Immune Evasion and Aerobic Glycolysis"],"prefix":"10.1007","volume":"82","author":[{"given":"Fatao","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,13]]},"reference":[{"key":"1342_CR1","doi-asserted-by":"crossref","unstructured":"Afifi, A. M., Elgenidy, A., Hashim, M., Awad, A. K., & Jalal, P. K. (2022). Hepatitis B virus core-related antigen (HBcrAg) as a prognostic marker for the development of hepatocellular carcinoma: A mini systematic review of the literature. Reviews in Medical Virology, 32, e2353.","DOI":"10.1002\/rmv.2353"},{"key":"1342_CR2","doi-asserted-by":"crossref","unstructured":"Au, K. P., Chan, M. Y., Chu, K. W., Kwan, C. L. Y., Ma, K. W., She, W. H., Tsang, S. H. Y., Dai, W. C., Cheung, T. T., & Chan, A. C. Y. (2022). Impact of Three-Dimensional (3D) visualization on laparoscopic hepatectomy for hepatocellular carcinoma. Annals of Surgical Oncology, 29, 6731\u20136744.","DOI":"10.1245\/s10434-022-11716-9"},{"key":"1342_CR3","doi-asserted-by":"crossref","unstructured":"Kumar, A. R., Nair, A. L, B., Mathew, B., Sugunan, S., & Nath, L. R. (2022). Decoding the mechanism of drugs of heterocyclic nature against hepatocellular carcinoma. Anti-cancer Agents in Medicinal Chemistry, 23, 882\u2013893.","DOI":"10.2174\/1871520622666220418115310"},{"key":"1342_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.125","volume":"3","author":"J Li","year":"2022","unstructured":"Li, J., Zhou, J. K., Mu, X., Shen, S., Xu, X., Luo, Y., Luo, Y., Ming, Y., Wu, Y., & Peng, Y. (2022). Regulation of XPO5 phosphorylation by PP2A in hepatocellular carcinoma. MedComm, 3, e125.","journal-title":"MedComm"},{"key":"1342_CR5","doi-asserted-by":"crossref","unstructured":"Zhu, A. X., Dayyani, F., Yen, C. J., Ren, Z., Bai, Y., Meng, Z., Pan, H., Dillon, P., Mhatre, S. K., Gaillard, V. E., Hernandez, S., Kelley, R. K., & Sangro, B. (2022). Alpha-fetoprotein as a potential surrogate biomarker for atezolizumab + bevacizumab treatment of hepatocellular carcinoma. Clinical Cancer Research, 28, 3537\u20133545.","DOI":"10.1158\/1078-0432.CCR-21-3275"},{"key":"1342_CR6","doi-asserted-by":"publisher","first-page":"773570","DOI":"10.3389\/fimmu.2021.773570","volume":"12","author":"L Guo","year":"2021","unstructured":"Guo, L., Yang, H., Zhou, C., Shi, Y., Huang, L., & Zhang, J. (2021). N6-Methyladenosine RNA modification in the tumor immune microenvironment: novel implications for immunotherapy. Frontiers in Immunology, 12, 773570.","journal-title":"Frontiers in Immunology"},{"key":"1342_CR7","doi-asserted-by":"publisher","first-page":"783322","DOI":"10.3389\/fcell.2021.783322","volume":"9","author":"M Huang","year":"2021","unstructured":"Huang, M., Xu, S., Liu, L., Zhang, M., Guo, J., Yuan, Y., Xu, J., Chen, X., & Zou, J. (2021). m6A methylation regulates osteoblastic differentiation and bone remodeling. Frontiers in Cell and Developmental Biology, 9, 783322.","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"1342_CR8","doi-asserted-by":"publisher","first-page":"825109","DOI":"10.3389\/fgene.2021.825109","volume":"12","author":"Q Liu","year":"2021","unstructured":"Liu, Q. (2021). Current advances in N6-Methyladenosine methylation modification during bladder cancer. Frontiers in Genetics, 12, 825109.","journal-title":"Frontiers in Genetics"},{"key":"1342_CR9","doi-asserted-by":"publisher","first-page":"4843","DOI":"10.2147\/DMSO.S344472","volume":"14","author":"G Luo","year":"2021","unstructured":"Luo, G., Chen, J., & Ren, Z. (2021). Regulation of Methylase METTL3 on fat deposition. Diabetes Metabolic Syndrome and Obesity, 14, 4843\u20134852.","journal-title":"Diabetes Metabolic Syndrome and Obesity"},{"key":"1342_CR10","first-page":"13423","volume":"13","author":"Y Li","year":"2021","unstructured":"Li, Y., Cheng, X., Chen, Y., Zhou, T., Li, D., & Zheng, W. V. (2021). METTL3 facilitates the progression of hepatocellular carcinoma by modulating the m6A level of USP7. American Journal of Translational Research, 13, 13423\u201313437.","journal-title":"American Journal of Translational Research"},{"key":"1342_CR11","doi-asserted-by":"publisher","first-page":"10197","DOI":"10.1111\/jcmm.16957","volume":"25","author":"Z Fan","year":"2021","unstructured":"Fan, Z., Yang, G., Zhang, W., Liu, Q., Liu, G., Liu, P., Xu, L., Wang, J., Yan, Z., Han, H., Liu, R., & Shu, M. (2021). Hypoxia blocks ferroptosis of hepatocellular carcinoma via suppression of METTL14 triggered YTHDF2-dependent silencing of SLC7A11. Journal of Cellular and Molecular Medicine, 25, 10197\u201310212.","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"1342_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1053-8","volume":"18","author":"Y Chen","year":"2019","unstructured":"Chen, Y., Peng, C., Chen, J., Chen, D., Yang, B., He, B., Hu, W., Zhang, Y., Liu, H., Dai, L., Xie, H., Zhou, L., Wu, J., & Zheng, S. (2019). WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1. Molecular Cancer, 18, 127.","journal-title":"Molecular Cancer"},{"key":"1342_CR13","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1158\/0008-5472.CAN-21-1323","volume":"82","author":"Z Ni","year":"2022","unstructured":"Ni, Z., Sun, P., Zheng, J., Wu, M., Yang, C., Cheng, M., Yin, M., Cui, C., Wang, G., Yuan, L., Gao, Q., & Li, Y. (2022). JNK signaling promotes bladder cancer immune escape by regulating METTL3-Mediated m6A Modification of PD-L1 mRNA. Cancer Research, 82, 1789\u20131802.","journal-title":"Cancer Research"},{"key":"1342_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42883-2","volume":"14","author":"X Ren","year":"2023","unstructured":"Ren, X., Cheng, Z., He, J., Yao, X., Liu, Y., Cai, K., Li, M., Hu, Y., & Luo, Z. (2023). Inhibition of glycolysis-driven immunosuppression with a nano-assembly enhances response to immune checkpoint blockade therapy in triple negative breast cancer. Nature Communications, 14, 7021.","journal-title":"Nature Communications"},{"key":"1342_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-52160-x","volume":"14","author":"S Cho","year":"2024","unstructured":"Cho, S., Kim, W., Yoo, D., Han, Y., Hwang, H., Kim, S., Kim, J., Park, S., Park, Y., Jo, H., Pyun, J. C., & Lee, M. (2024). Impact of glucose metabolism on PD-L1 expression in sorafenib-resistant hepatocellular carcinoma cells. Scientific Reports, 14, 1751.","journal-title":"Scientific Reports"},{"key":"1342_CR16","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/hep.31313","volume":"73","author":"GW Kim","year":"2021","unstructured":"Kim, G. W., Imam, H., Khan, M., Mir, S. A., Kim, S. J., Yoon, S. K., Hur, W., & Siddiqui, A. (2021). HBV-induced increased N6 Methyladenosine Modification of PTEN RNA affects innate immunity and contributes to HCC. Hepatology, 73, 533\u2013547.","journal-title":"Hepatology"},{"key":"1342_CR17","doi-asserted-by":"publisher","first-page":"1144774","DOI":"10.3389\/fimmu.2023.1144774","volume":"14","author":"H Wang","year":"2023","unstructured":"Wang, H., Tang, A., Cui, Y., Gong, H., & Li, H. (2023). LRPPRC facilitates tumor progression and immune evasion through upregulation of m(6)A modification of PD-L1 mRNA in hepatocellular carcinoma. Frontiers in Immunology, 14, 1144774.","journal-title":"Frontiers in Immunology"},{"key":"1342_CR18","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202300344RRR","volume":"37","author":"M Ye","year":"2023","unstructured":"Ye, M., Chen, J., Yu, P., Hu, C., Wang, B., Bao, J., Lu, F., Zhong, Y., Yan, L., Kan, J., Bai, J., Tian, Y., Tang, Q., & activates, W. T. A. P. (2023). MAPK signaling through m6A methylation in VEGFA mRNA-mediated by YTHDC1 to promote colorectal cancer development. FASEB Journal, 37, e23090.","journal-title":"FASEB Journal"},{"issue":"5","key":"1342_CR19","first-page":"633","volume":"39","author":"J Wang","year":"2023","unstructured":"Wang, J., Luo, J., Wu, X., & Li, Z. (2023). WTAP enhances the instability of SYTL1 mRNA caused by YTHDF2 in bladder cancer. Histology, and Histopathology, 39(5), 633\u2013646.","journal-title":"Histology, and Histopathology"},{"key":"1342_CR20","doi-asserted-by":"crossref","unstructured":"Ju, G., Lei, J., Cai, S., Liu, S., Yin, X., & Peng, C. (2023). The emerging, multifaceted role of WTAP in Cancer and Cancer Therapeutics. Cancers, 15, 3053.","DOI":"10.3390\/cancers15113053"},{"key":"1342_CR21","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41419-022-05268-9","volume":"13","author":"Q Huang","year":"2022","unstructured":"Huang, Q., Mo, J., Liao, Z., Chen, X., & Zhang, B. (2022). The RNA m(6)A writer WTAP in diseases: structure, roles, and mechanisms. Cell Death and Disease, 13, 852.","journal-title":"Cell Death and Disease"},{"key":"1342_CR22","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.dld.2022.12.005","volume":"55","author":"S Chen","year":"2023","unstructured":"Chen, S., Xia, H., & Sheng, L. (2023). WTAP-mediated m6A modification on circCMTM3 inhibits hepatocellular carcinoma ferroptosis by recruiting IGF2BP1 to increase PARK7 stability. Digestive and Liver Disease, 55, 967\u2013981.","journal-title":"Digestive and Liver Disease"},{"key":"1342_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01759-1","volume":"22","author":"Z Hu","year":"2023","unstructured":"Hu, Z., Chen, G., Zhao, Y., Gao, H., Li, L., Yin, Y., Jiang, J., Wang, L., Mang, Y., Gao, Y., Zhang, S., Ran, J., & Li, L. (2023). Exosome-derived circCCAR1 promotes CD8+\u2009T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma. Molecular Vancer, 22, 55.","journal-title":"Molecular Vancer"},{"issue":"6","key":"1342_CR24","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1111\/cas.16136","volume":"115","author":"QZ Liu","year":"2024","unstructured":"Liu, Q. Z., Zhang, N., Chen, J. Y., Zhou, M. J., Zhou, D. H., Chen, Z., Huang, Z. X., Xie, Y. X., Qiao, G. L., & Tu, X. H. (2024). WTAP-induced N(6)-methyladenosine of PD-L1 blocked T-cell-mediated antitumor activity under hypoxia in colorectal cancer. Cancer Science, 115(6), 1749\u20131762.","journal-title":"Cancer Science"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01342-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-024-01342-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01342-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T14:21:54Z","timestamp":1727792514000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-024-01342-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,13]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["1342"],"URL":"https:\/\/doi.org\/10.1007\/s12013-024-01342-5","relation":{},"ISSN":["1085-9195","1559-0283"],"issn-type":[{"value":"1085-9195","type":"print"},{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,13]]},"assertion":[{"value":"29 May 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study had been approved by the Animal Welfare Committee of Zibo Central Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Statement"}}]}}